National Medical Care Company (4005) Fair Value & Analysis
Healthcare · SA · Market cap 5.1B SAR
Fair value as of: Jul 31, 2026
From 26 valuation models · updated today
Share price +9.1% over the past month.
What matters now
- The model range is unusually wide (57.18 SAR to 164.60 SAR). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
Price vs Fair Value (12 months)
12‑month range 97.90 SAR – 177.46 SAR · fair‑value band 57.18 SAR – 164.60 SAR · the 113.00 SAR price screens above the 110.34 SAR fair value. As of Jul 31, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
National Medical Care Company (4005) currently trades at 113.00 SAR, while our model-based Fair Value estimate is 110.34 SAR, implying the stock looks roughly 2.4% fairly valued today. We read business quality at 52/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, National Medical Care Company generated revenue of 1.6B SAR at a net margin of 17.8%. Revenue grew 0.7% year over year. It earns a return on equity of 15.8%. Net debt stands at 188M SAR. Fundamentals as of Jul 31, 2026
Our scenario range runs from 57.18 SAR (bear case) to 164.60 SAR (bull case); at 113.00 SAR, the current price sits within that range. The share trades about 37% below its 52-week high and 19% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -19% fair-value upside, at -2%, 4005 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 31, 2026. TTM = trailing twelve months.
Quality Score breakdown
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
National Medical Care Company, together with its subsidiaries, owns, establishes, equips, manages, maintains, and operates healthcare facilities in the Kingdom of Saudi Arabia. It also provides home health care services. The company was founded in 2003 and is based in Riyadh, the Kingdom of Saudi Arabia.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
National Medical Care Company reported revenue of 1.6B SAR in FY2025 versus 845M SAR in FY2021, a compound +17.3%/yr. Reported net income was 318M SAR in FY2025, compounding +23.6%/yr from FY2021.
Is 4005 fairly valued? → Check now
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 31, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$100.00 | R$25.67 | -74% |
| Fresenius SE FRE | €39.54 | €31.98 | -19% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.76 SGD | 1.28 SGD | -54% |
| Tenet Healthcare Corporation THC | $178.75 | $300.86 | +68% |
| Rede D'Or São Luiz S.A RDOR3 | R$32.50 | R$46.04 | +42% |
| DaVita Inc DVAI34 | R$1,002 | R$1,038 | +4% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,305 | ₹2,546 | -69% |
| Fresenius Medical Care AG FMSC34 | R$112.00 | R$164.60 | +47% |
| Aier Eye Hospital Group 300015 | ¥8.54 | ¥6.73 | -21% |
Compare National Medical Care Company with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is National Medical Care Company (4005) overvalued or undervalued?
What is the fair value of 4005?
What is the quality score of 4005?
What is the revenue of National Medical Care Company (4005)?
What is the net profit margin of 4005?
Does National Medical Care Company pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track National Medical Care Company and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.